Sökning: "Inflammatory Markers"
Visar resultat 11 - 15 av 555 avhandlingar innehållade orden Inflammatory Markers.
11. Cervical and intra-amniotic markers of preterm birth and infection
Sammanfattning : Abstract Background: Preterm delivery (PTD; < 37 gestational weeks), is one of the greatest unsolved obstetrical problems worldwide. As much as 80% of the perinatal mortality and 50% of the long-term neurological handicaps are associated with PTD. Spontaneous preterm birth (SPTD), i.e. LÄS MER
12. Towards Heart Rate Variability Tools in P-Health : Pervasive, Preventive, Predictive and Personalized
Sammanfattning : Heart rate variability (HRV) has received much attention lately. It has been shown that HRV can be used to monitor the autonomic nervous system and to detect autonomic dysfunction, especially vagal dysfunction. Reduced HRV is associated with several diseases and has also been suggested as a predictor of poor outcomes and sudden cardiac death. LÄS MER
13. Severe sepsis : epidemiology and sex-related differences in inflammatory markers
Sammanfattning : Background. Sepsis is a syndrome associated with high mortality rates, substantial morbidity and high costs of care. The incidents of sepsis is reported to be high and controversy exists whether gender affect severity or outcome. LÄS MER
14. Bad breath : prevalence, periodontal disease, microflora and inflammatory markers
Sammanfattning : Bad breath usually originates within the oral cavity and is believed to be associated with periodontal disease. The over all aim of the present thesis was to study periodontal conditions in subjects with bad breath as well as the prevalence of bad breath in subjects with periodontal disease. LÄS MER
15. Biomolecular markers in head and neck cancer
Sammanfattning : Head and neck cancer is a heterogeneous group of tumours, of which certain subgroups such as cancer of the mobile tongue frequently are associated with a relatively poor prognosis due to the high risk of regional failure and mortality rates that haven’t improved in a significant way over the last 3 decades, despite advancements in both diagnostics and treatment.Today we lack means to assess the biological aggressiveness of each individual tumour, which varies largely. LÄS MER